182 related articles for article (PubMed ID: 28910864)
1. Madurahydroxylactone, an Inhibitor of
Kim BM; Choi HY; Kim GW; Zheng CJ; Kim YH; Kim WG
J Microbiol Biotechnol; 2017 Nov; 27(11):1994-1998. PubMed ID: 28910864
[TBL] [Abstract][Full Text] [Related]
2. New mechanism of magnolol and honokiol from Magnolia officinalis against Staphylococcus aureus.
Liu T; Pan Y; Lai R
Nat Prod Commun; 2014 Sep; 9(9):1307-9. PubMed ID: 25918799
[TBL] [Abstract][Full Text] [Related]
3. An improved small-molecule inhibitor of FtsZ with superior in vitro potency, drug-like properties, and in vivo efficacy.
Stokes NR; Baker N; Bennett JM; Berry J; Collins I; Czaplewski LG; Logan A; Macdonald R; Macleod L; Peasley H; Mitchell JP; Nayal N; Yadav A; Srivastava A; Haydon DJ
Antimicrob Agents Chemother; 2013 Jan; 57(1):317-25. PubMed ID: 23114779
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and on-target antibacterial activity of novel 3-elongated arylalkoxybenzamide derivatives as inhibitors of the bacterial cell division protein FtsZ.
Ma S; Cong C; Meng X; Cao S; Yang H; Guo Y; Lu X; Ma S
Bioorg Med Chem Lett; 2013 Jul; 23(14):4076-9. PubMed ID: 23770057
[TBL] [Abstract][Full Text] [Related]
5. Structural and Antibacterial Characterization of a New Benzamide FtsZ Inhibitor with Superior Bactericidal Activity and In Vivo Efficacy Against Multidrug-Resistant
Bryan E; Ferrer-González E; Sagong HY; Fujita J; Mark L; Kaul M; LaVoie EJ; Matsumura H; Pilch DS
ACS Chem Biol; 2023 Mar; 18(3):629-642. PubMed ID: 36854145
[TBL] [Abstract][Full Text] [Related]
6. FtsZ inhibition: a promising approach for antistaphylococcal therapy.
Singh P; Panda D
Drug News Perspect; 2010 Jun; 23(5):295-304. PubMed ID: 20603653
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis of novel 4,5-dihydroisoxazole-containing benzamide derivatives as highly potent FtsZ inhibitors capable of killing a variety of MDR Staphylococcus aureus.
Song D; Bi F; Zhang N; Qin Y; Liu X; Teng Y; Ma S
Bioorg Med Chem; 2020 Nov; 28(21):115729. PubMed ID: 33065440
[TBL] [Abstract][Full Text] [Related]
8. Antisense growth inhibition of methicillin-resistant Staphylococcus aureus by locked nucleic acid conjugated with cell-penetrating peptide as a novel FtsZ inhibitor.
Meng J; Da F; Ma X; Wang N; Wang Y; Zhang H; Li M; Zhou Y; Xue X; Hou Z; Jia M; Luo X
Antimicrob Agents Chemother; 2015 Feb; 59(2):914-22. PubMed ID: 25421468
[TBL] [Abstract][Full Text] [Related]
9. A bactericidal guanidinomethyl biaryl that alters the dynamics of bacterial FtsZ polymerization.
Kaul M; Parhi AK; Zhang Y; LaVoie EJ; Tuske S; Arnold E; Kerrigan JE; Pilch DS
J Med Chem; 2012 Nov; 55(22):10160-76. PubMed ID: 23050700
[TBL] [Abstract][Full Text] [Related]
10. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.
Tan CM; Therien AG; Lu J; Lee SH; Caron A; Gill CJ; Lebeau-Jacob C; Benton-Perdomo L; Monteiro JM; Pereira PM; Elsen NL; Wu J; Deschamps K; Petcu M; Wong S; Daigneault E; Kramer S; Liang L; Maxwell E; Claveau D; Vaillancourt J; Skorey K; Tam J; Wang H; Meredith TC; Sillaots S; Wang-Jarantow L; Ramtohul Y; Langlois E; Landry F; Reid JC; Parthasarathy G; Sharma S; Baryshnikova A; Lumb KJ; Pinho MG; Soisson SM; Roemer T
Sci Transl Med; 2012 Mar; 4(126):126ra35. PubMed ID: 22440737
[TBL] [Abstract][Full Text] [Related]
11. Effective GTP-replacing FtsZ inhibitors and antibacterial mechanism of action.
Artola M; Ruiz-Avila LB; Vergoñós A; Huecas S; Araujo-Bazán L; Martín-Fontecha M; Vázquez-Villa H; Turrado C; Ramírez-Aportela E; Hoegl A; Nodwell M; Barasoain I; Chacón P; Sieber SA; Andreu JM; López-Rodríguez ML
ACS Chem Biol; 2015 Mar; 10(3):834-43. PubMed ID: 25486266
[TBL] [Abstract][Full Text] [Related]
12. An inhibitor of FtsZ with potent and selective anti-staphylococcal activity.
Haydon DJ; Stokes NR; Ure R; Galbraith G; Bennett JM; Brown DR; Baker PJ; Barynin VV; Rice DW; Sedelnikova SE; Heal JR; Sheridan JM; Aiwale ST; Chauhan PK; Srivastava A; Taneja A; Collins I; Errington J; Czaplewski LG
Science; 2008 Sep; 321(5896):1673-5. PubMed ID: 18801997
[TBL] [Abstract][Full Text] [Related]
13. Boosting the efficacy of anti-MRSA β-lactam antibiotics via an easily accessible, non-cytotoxic and orally bioavailable FtsZ inhibitor.
Lui HK; Gao W; Cheung KC; Jin WB; Sun N; Kan JWY; Wong ILK; Chiou J; Lin D; Chan EWC; Leung YC; Chan TH; Chen S; Chan KF; Wong KY
Eur J Med Chem; 2019 Feb; 163():95-115. PubMed ID: 30503946
[TBL] [Abstract][Full Text] [Related]
14. TXA709, an FtsZ-Targeting Benzamide Prodrug with Improved Pharmacokinetics and Enhanced In Vivo Efficacy against Methicillin-Resistant Staphylococcus aureus.
Kaul M; Mark L; Zhang Y; Parhi AK; Lyu YL; Pawlak J; Saravolatz S; Saravolatz LD; Weinstein MP; LaVoie EJ; Pilch DS
Antimicrob Agents Chemother; 2015 Aug; 59(8):4845-55. PubMed ID: 26033735
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting the growth of methicillin-resistant Staphylococcus aureus in vitro with antisense peptide nucleic acid conjugates targeting the ftsZ gene.
Liang S; He Y; Xia Y; Wang H; Wang L; Gao R; Zhang M
Int J Infect Dis; 2015 Jan; 30():1-6. PubMed ID: 25447735
[TBL] [Abstract][Full Text] [Related]
16. A Carbocyclic Curcumin Inhibits Proliferation of Gram-Positive Bacteria by Targeting FtsZ.
Groundwater PW; Narlawar R; Liao VW; Bhattacharya A; Srivastava S; Kunal K; Doddareddy M; Oza PM; Mamidi R; Marrs EC; Perry JD; Hibbs DE; Panda D
Biochemistry; 2017 Jan; 56(3):514-524. PubMed ID: 28002947
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and structure-activity relationships of substituted oxazole-benzamide antibacterial inhibitors of FtsZ.
Stokes NR; Baker N; Bennett JM; Chauhan PK; Collins I; Davies DT; Gavade M; Kumar D; Lancett P; Macdonald R; Macleod L; Mahajan A; Mitchell JP; Nayal N; Nayal YN; Pitt GR; Singh M; Yadav A; Srivastava A; Czaplewski LG; Haydon DJ
Bioorg Med Chem Lett; 2014 Jan; 24(1):353-9. PubMed ID: 24287381
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.
Liu H; Zhao Y; Zhao D; Gong T; Wu Y; Han H; Xu T; Peschel A; Han S; Qu D
Emerg Microbes Infect; 2015 Jan; 4(1):e1. PubMed ID: 26038759
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of Staphylococcus aureus carriers of mecA gene susceptible to cefoxitine: OS-MRSA].
Aleixandre-Górriz I; Domínguez-Márquez MV; Martínez-Macías O; Colomina J; Guerrero A
Rev Esp Quimioter; 2014 Sep; 27(3):215-6. PubMed ID: 25229377
[No Abstract] [Full Text] [Related]
20. Mechanism of action of the cell-division inhibitor PC190723: modulation of FtsZ assembly cooperativity.
Elsen NL; Lu J; Parthasarathy G; Reid JC; Sharma S; Soisson SM; Lumb KJ
J Am Chem Soc; 2012 Aug; 134(30):12342-5. PubMed ID: 22793495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
